Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

Webinar icon

Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency

Commissioned by Norgine Pharmaceuticals Limited

Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021

FINAL video image

Management of obesity in primary care: a Guidelines algorithm

Funded by Novo Nordisk Limited

Information intended for UK healthcare professionals only. These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos. 
Date of preparation: December 2021

index

Management of common eye conditions: blepharitis

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.

index 2

Management of common eye conditions: conjunctivitis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.

dry eye index image

Management of common eye conditions: dry eye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.

foreign bodies index image

Management of common eye conditions: corneal and subtarsal foreign bodies

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.

chalazion index image 2

Management of common eye conditions: chalazion (meibomian cyst)

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the presentation and management of chalazion (meibomian cyst).

index image

Management of common eye conditions: corneal abrasion

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses the causes, symptoms, and treatment of corneal abrasion.

index image

Management of common eye conditions: subconjunctival haemorrhage

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance and causes of subconjunctival haemorrhage.

episcleritis screenshot 2 (index)

Management of common eye conditions: episcleritis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the causes, symptoms, and treatment of episcleritis.

Stye index image screenshot

Management of common eye conditions: stye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the appearance, symptoms, and treatment of stye.

eye drop demo image

Management of common eye conditions: Glaucoma and the #knowyourdrops campaign

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses treatment of glaucoma and techniques for correct eye drop administration.

Introduction 1

Management of common eye conditions: introduction

Funded by Allergan plc

Sarah Thomas and Fiona Chiu introduce a new video series on the management of common eye conditions and the #knowyourdrops eye drops compliance campaign.

Measuring blood sugar on finger_AS

Best practice treatment and management of patients with type 2 diabetes, cardiovascular disease, and heart failure

By Development Group—Javaid (Chair) Anand Assomull Holmes Karalliedde

This management algorithm was developed by a multidisciplinary expert panel: Javaid et al with the support of an educational grant from AstraZeneca. Information intended for UK healthcare professionals.

Final version - HE algorithm

Management of hepatic encephalopathy in primary care

Commissioned by Norgine Pharmaceuticals Limited

This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
View TARGAXAN® (rifaximin-α) prescribing and adverse event reporting information
UK-HEP-XIF-2100040  October 2021

A nurse consulting with a woman in WPG Yellow

Guideline for the managed introduction of biosimilar bolus insulin in individuals with type 2 diabetes

By Working party–Down Beba Davies Diggle Goel

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Sanofi Ltd.

Stack of fruits, white weight scale and tailor meter on wooden board_AS

Managing obesity in primary care

By Development Group—Tahrani Parretti O’Kane Chowhan Ratcliffe and Le Brocq

This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.

AdobeStock_212764468

Identifying and managing allergic rhinitis in the asthma population

By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

DuoResp Spiromax (budesonide:formoterol) prescribing summary card

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com.

Click here for prescribing information and adverse event reporting

DUOR-GB-00117
Date of preparation: March 2022